3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
Protothecosis is an unusual infection of both humans and animals caused by opportunistically pathogenic microalgae of the genus Prototheca. Until now, no standardized treatment protocols exist for the protothecal disease, boosted by a remarkable resistance of Prototheca spp. to a wide array of antim...
Main Authors: | Tomasz Jagielski, Katarzyna Niedźwiecka, Katarzyna Roeske, Mariusz Dyląg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00375/full |
Similar Items
-
Cutaneous protothecosis in a dog successfully treated with oral itraconazole in pulse dosing
by: Vanessa Cunningham Gmyterco, et al.
Published: (2023-02-01) -
Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
by: Natalia Pieńkowska, et al.
Published: (2021-01-01) -
RETRACTED: Ppm1b Negatively Regulates 3-Bromopyruvate Induced Necroptosis in Breast Cancer Cells
by: Yiming Sun, et al.
Published: (2021-01-01) -
Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate
by: Magdalena Cal, et al.
Published: (2021-06-01) -
Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against Echinococcus multilocularis protoscoleces
by: Hirokazu Kouguchi, et al.
Published: (2022-12-01)